Axsome Therapeutics, Inc. (AXSM)
186.98
-2.12
(-1.12%)
USD |
NASDAQ |
Jan 22, 16:00
186.98
0.00 (0.00%)
Pre-Market: 08:04
Axsome Therapeutics Research and Development Expense (TTM): 188.68M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Corcept Therapeutics, Inc. | 260.35M |
| Gilead Sciences, Inc. | 5.734B |
| Vanda Pharmaceuticals, Inc. | 100.10M |
| Amicus Therapeutics, Inc. | 142.29M |
| MannKind Corp. | 49.90M |